Home › Amyloidosis › Washington
Amyloidosis clinical trials in Washington
4 studies for Amyloidosis are looking for participants at sites in Washington.
Cities in Washington
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Seattle
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Seattle
- Clinical Trial Site, Spokane
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- University of Washington /ID# 261581, Seattle
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06158854From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.